Back to today’s briefing

Story perspectives

Breakthrough in Nanomedicine: FDA Drugs Enhance Safety

7/10/2025

38 7

Summary

Story summary

Researchers at the University of Colorado Anschutz Medical Campus have made a groundbreaking discovery in nanomedicine safety by repurposing FDA-approved drugs. Their study, featured in Science Advances, reveals that immune-modulating drugs such as iptacopan can significantly lessen harmful immune reactions to nanoparticles, paving the way for more effective treatments for cancer and infections.

1 of 1

Story summary

Researchers at the University of Colorado Anschutz Medical Campus have made a groundbreaking discovery in nanomedicine safety by repurposing FDA-approved drugs. Their study, featured in Science Advances, reveals that immune-modulating drugs such as iptacopan can significantly lessen harmful immune reactions to nanoparticles, paving the way for more effective treatments for cancer and infections.